Roberts Glore & Co. Inc. IL raised its position in NICE Ltd. (NASDAQ:NICE – Free Report) by 62.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,356 shares of the technology company’s stock after acquiring an additional 910 shares during the quarter. Roberts Glore & Co. Inc. IL’s holdings in NICE were worth $400,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in NICE. Van ECK Associates Corp lifted its stake in NICE by 1.6% in the third quarter. Van ECK Associates Corp now owns 21,766 shares of the technology company’s stock worth $3,820,000 after acquiring an additional 337 shares during the last quarter. ARK Investment Management LLC lifted its stake in NICE by 20.2% in the third quarter. ARK Investment Management LLC now owns 11,308 shares of the technology company’s stock worth $1,964,000 after acquiring an additional 1,899 shares during the last quarter. Seascape Capital Management lifted its stake in NICE by 5.6% in the third quarter. Seascape Capital Management now owns 13,063 shares of the technology company’s stock worth $2,269,000 after acquiring an additional 696 shares during the last quarter. Atria Investments Inc purchased a new position in NICE in the third quarter worth approximately $215,000. Finally, Mesirow Financial Investment Management Inc. lifted its stake in NICE by 7.5% in the third quarter. Mesirow Financial Investment Management Inc. now owns 10,214 shares of the technology company’s stock worth $1,774,000 after acquiring an additional 712 shares during the last quarter. Hedge funds and other institutional investors own 63.34% of the company’s stock.
NICE Price Performance
NICE stock opened at $149.80 on Friday. The company has a fifty day moving average price of $163.80 and a 200 day moving average price of $171.40. NICE Ltd. has a 12 month low of $137.19 and a 12 month high of $270.73. The company has a market cap of $9.42 billion, a price-to-earnings ratio of 22.16, a price-to-earnings-growth ratio of 1.07 and a beta of 1.12.
Analyst Ratings Changes
NICE has been the subject of a number of recent research reports. Barclays decreased their price target on shares of NICE from $286.00 to $226.00 and set an “overweight” rating for the company in a research note on Friday, February 21st. Cantor Fitzgerald decreased their price target on shares of NICE from $176.00 to $161.00 and set a “neutral” rating for the company in a research note on Friday, February 21st. DA Davidson reduced their price objective on shares of NICE from $300.00 to $225.00 and set a “buy” rating for the company in a research report on Friday, November 15th. Northland Securities reduced their price objective on shares of NICE from $275.00 to $250.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. Finally, Royal Bank of Canada reduced their price objective on shares of NICE from $260.00 to $200.00 and set an “outperform” rating for the company in a research report on Friday, February 21st. Four equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $231.64.
Read Our Latest Report on NICE
About NICE
NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing.
Read More
- Five stocks we like better than NICE
- How to Effectively Use the MarketBeat Ratings Screener
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Investing In Preferred Stock vs. Common Stock
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Want to see what other hedge funds are holding NICE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NICE Ltd. (NASDAQ:NICE – Free Report).
Receive News & Ratings for NICE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NICE and related companies with MarketBeat.com's FREE daily email newsletter.